After multiple studies have suggested a link between its shingles vaccine and dementia prevention, GSK is taking advantage of ...

The arc of biotechnology is one of breakthroughs and struggles, writes Tim Hunt, CEO of the Alliance for Regenerative ...

Corient Private Wealth LLC increased its position in Sana Biotechnology, Inc. (NASDAQ:SANA – Free Report) by 161.7% in the fourth quarter, according to its most recent disclosure with the SEC. The ...

Microalgae have emerged as a promising bioresource for sustainable biotechnological applications, aligning with global efforts towards eco-friendly ...

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take ...

The big biotech signed a 15-year lease for approximately 580,000-square-feet of space in “Kendall Commons,” a development project spearheaded by MIT.

Philanthropies, especially from venture-minded or justice-driven donors, could step in where policy has stalled. By funding ...

Scoop ...Haun Ventures, the crypto venture giant that raised $1.5 billion across two funds back near the height of the last blockchain bull market in 2022, is out raising its second round of funds, ...

In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.

Zacks Research cut their Q2 2026 earnings estimates for shares of BioMarin Pharmaceutical in a research report issued on Wednesday, March 19th. Zacks Research analyst S. Ganoria now expects that the ...

According to a report by Mordor Intelligence, the clinical diagnostics market has a size of $88.79 billion as of 2025.

Why didn’t analysts share the same fear that gripped investors about Sarepta stock? One reason is the known risk of acute liver injury associated with adeno-associated virus vector (AAV)-based gene ...